Your session will expire in:
The 26th World Congress on Gastrointestinal Cancer
Centre de Convencions Internacional de Barcelona
Barcelona, Spain
3 - 6 July 2024
Barcelona, Spain
3 - 6 July 2024
ATTENTION: 2024 World Congress on Gastrointestinal Cancer conference has been suspended.
You are welcome to submit your abstract at another, relevant conference.
For more information, please visit https://www.hmpglobalevents.com/wgi
For more information, please visit https://www.hmpglobalevents.com/wgi
Instructions to Submitters
- The presenting author’s affiliation cannot be a pharmaceutical company and they must register, attend, and present at the Congress. Presenters do not need to be an ESMO Member.
- Ensure all email addresses are correct.
- There are no graphic uploads allowed.
- Single author submissions will not be considered
- If you need technical or association assistance, please use the email support form on each page.
- Once you are complete, please click on ‘finalize submission’ on the final page to complete your submission.
- Revisit the site as often as necessary to complete your submission.
- The back and forward browser arrows have been disabled; please use the menu progress bar at the top right-hand corner of the pages to return to previous pages.
- Users must use the following browsers: Mozilla Firefox 4+, Safari 5+, Chrome 14+, Opera 11.5+, MS Edge. We do not recommend Internet Explorer.
- At any point in the abstract process, the submitter of the abstract can log into submission to view your abstract details and any correspondence about your submission(s).
- Note on email communications: Please add @owpm1.com as a safe sender in your email program. If you do not do this, your email spam filter may prevent you from receiving important emails regarding your submission(s). For more information on adding safe senders for your mail server, click here.
Guidelines
Participants interested in presenting data should submit abstracts online by 11 APRIL 2024. Abstracts are subject to acceptance by the Scientific Committee. Once accepted, abstracts will be published in a supplement of The Oncologist and scheduled for oral or poster presentation. Acceptance notifications and guidelines for podium and poster presentations will be sent on 23 APRIL 2024. Authors of accepted abstracts who have not registered will have until 10 MAY 2024 to do so at the early registration rate.
Abstracts will be accepted in the following categories, and the author should indicate it as either BASIC or CLINICAL by choosing the appropriate category in the online submission system:
Participants interested in presenting data should submit abstracts online by 11 APRIL 2024. Abstracts are subject to acceptance by the Scientific Committee. Once accepted, abstracts will be published in a supplement of The Oncologist and scheduled for oral or poster presentation. Acceptance notifications and guidelines for podium and poster presentations will be sent on 23 APRIL 2024. Authors of accepted abstracts who have not registered will have until 10 MAY 2024 to do so at the early registration rate.
Abstracts will be accepted in the following categories, and the author should indicate it as either BASIC or CLINICAL by choosing the appropriate category in the online submission system:
• Colon Cancer
• Esophageal Cancer
• Gastric Cancer
• Hepatocellular Carcinoma
• Pancreatic Cancer
• Rectal Cancer
• Biliary Tract Cancer
• Neuroendocrine Tumors
• Others (including GIST and Anal Cancer)
• Esophageal Cancer
• Gastric Cancer
• Hepatocellular Carcinoma
• Pancreatic Cancer
• Rectal Cancer
• Biliary Tract Cancer
• Neuroendocrine Tumors
• Others (including GIST and Anal Cancer)
Subcategories include:
• Biomarkers and Translational Research
• Early and Locally Advanced Disease
• Imaging
• Metastatic Disease
• Pathology
• Preclinical
• Radiotherapy
• Screening/Prevention/Epidemiology
• Surgery
• Others
Trials in Progress Abstract Submissions
The 26th World Congress on Gastrointestinal Cancer is accepting Trials in Progress abstract submissions in all phases of clinical research (phase I to phase III). All abstracts submitted as Trials in Progress are ongoing trials that have not reached any protocol-specific endpoint for analysis and will only require the completion of two sections: Background and Trial Design. It is a requirement that recruitment must have already begun or have been completed by the abstract submission deadline.
Abstract Guidelines
- Follow the online instructions
- Abstracts must be written in English
- All abstracts are considered for Oral Presentation. If not accepted for Oral, then ALL submissions will be considered for Poster Presentation
-
The submitted work must not, nor will not have been:
- published in any journal, or on any web site before 3 July 2024, or
- presented at any national or international scientific conference prior to 3 July 2024
- Encore abstracts will be allowed if they contain new data. During the submission process you will be asked if the abstract has been presented before, when you say yes you will be prompted to submit the original abstract as a reference.
- Abstract body must have a 500-word count limit.
- Use a concise title. Title should be in sentence case (eg: Using food science to enhance STEM education).
- List affiliations of author(s) as briefly as possible, with city, province/state and country.
- Maximum number of authors: 22.
- Use standard and well-accepted abbreviations.
- Abstract content should be single-spaced and typed in lower case.
- Abstracts shall be of original research and contain a concise statement of study aim.
- Submit four (4) parts of your abstract: Background, Method, Results, and Conclusion(s). Conclusions must be supported by your results and summarized within your abstract at the time of submission. Results “to be completed” and/or conclusions “to be discussed” are not acceptable.
- Abstract submissions can only be completed and finalized once all authors have submitted their disclosures. There is an ‘email author’ function to allow for submitters to send reminders to their co-authors to submit disclosures. The disclosure deadline will be the same as the submission deadline. NO exceptions will be made to this policy.
Developing Nations Travel Awards
A limited number (5) of travel awards are available for investigators from developing nations. Awards are available to investigators from the countries indicated in the 2024 World Bank List of Economies as Lower-Middle Income Economies. The complete list can be found at http://www.worldbank.org
These awards will consist of Congress registration and a grant in the amount of €1500 to cover airfare and hotel, given to the recipient at the Congress. Airfare can be purchased by HMP Global and deducted from this amount, if needed. If you have questions about this information, please contact HMP Global.
Developing Nations Travel Award recipients from past congresses will not be eligible for this award.
How to Apply for Developing Nations Travel Awards:
- The candidate must submit an abstract to The 26th World Congress on Gastrointestinal Cancer in the usual manner, indicating that the abstract is to be considered for the Developing Nations Award
- The candidate must be the first author of the submitted abstract
- The work must not have been presented or published before the date of The 26th World Congress on Gastrointestinal Cancer
- Abstracts must be submitted on schedule
-
Candidates should submit:
- A Curriculum Vitae
- A 1-3 page description of their interests and current research in gastrointestinal cancer signed and approved by their department chair
The Scientific Committee will select the award winners based on the scientific content of the abstract. Winners will be notified in April 2024.
Young Investigator Awards
A limited number (3) of Young Investigator Best Abstract Awards are available, upon application, to first author (= presenter) to candidates under the age of 40 who submit abstracts considered deserving of recognition.
These awards will consist of Congress registration and a grant in the amount of €1000, given to the recipient at the Congress. Airfare and hotel can be arranged by HMP Global for the Grant Recipient. The total amount of the airfare and hotel will be deducted from the grant amount awarded onsite. If you have questions about this information, please contact HMP Global.
Young Investigator Award recipients from past congresses will not be eligible for this award.
How do I apply for a young investigator award?
Young Investigator Awards
A limited number (3) of Young Investigator Best Abstract Awards are available, upon application, to first author (= presenter) to candidates under the age of 40 who submit abstracts considered deserving of recognition.
These awards will consist of Congress registration and a grant in the amount of €1000, given to the recipient at the Congress. Airfare and hotel can be arranged by HMP Global for the Grant Recipient. The total amount of the airfare and hotel will be deducted from the grant amount awarded onsite. If you have questions about this information, please contact HMP Global.
Young Investigator Award recipients from past congresses will not be eligible for this award.
How do I apply for a young investigator award?
- The candidate must submit an abstract to the 26th World Congress on Gastrointestinal Cancer in the usual manner, indicating that the abstract is to be considered for the Young Investigator Award during submission.
- To be considered for the Young Investigator Award, candidates will be required to submit a brief summary (cannot exceed 500 words) of the findings of the abstract and their relevance to the topics presented at the Congress.
- The age if the candidate should be less than 40 years of age by the submission deadline (Age will be verified).
- The candidate must be the first and presenting author of the submitted abstract.
- The work must not have been presented or published before the date of the 26th World Congress on Gastrointestinal Cancer.
The Scientific Committee will select the award winners based on the scientific content of the abstract. Winners will be notified in April 2024.
Late-Breaking Abstract Submissions
The Congress late-breaking policy allows the submission of late-breaking abstracts defined as “high quality, new research findings from randomized phase II or phase III trials with implications for clinical practice or understanding of disease processes.”
An abstract template should be submitted by the regular abstract deadline (11 APRIL 2024). The template should include: title, author list, and a description of the study. A final abstract version must be submitted by 13 JUNE, 2024 and will be published in a supplement of the The Oncologist. Abstract titles will be published on the meeting website ahead of the Congress. Please do not include any information you would like to remain embargoed in the title of your abstract.
Changes to Abstracts
You may change your abstract even after finalizing up until the submission deadline of 11 APRIL 2024, 17:00 CET. Once the submission site has closed, changes to abstracts will not be accepted.
Abstract Withdrawal
Deadline for withdrawing abstracts is 26 APRIL 2024. The Congress will not make any exceptions to this rule.
Important Abstract Dates
Late-Breaking Abstract Submissions
The Congress late-breaking policy allows the submission of late-breaking abstracts defined as “high quality, new research findings from randomized phase II or phase III trials with implications for clinical practice or understanding of disease processes.”
An abstract template should be submitted by the regular abstract deadline (11 APRIL 2024). The template should include: title, author list, and a description of the study. A final abstract version must be submitted by 13 JUNE, 2024 and will be published in a supplement of the The Oncologist. Abstract titles will be published on the meeting website ahead of the Congress. Please do not include any information you would like to remain embargoed in the title of your abstract.
Changes to Abstracts
You may change your abstract even after finalizing up until the submission deadline of 11 APRIL 2024, 17:00 CET. Once the submission site has closed, changes to abstracts will not be accepted.
Abstract Withdrawal
Deadline for withdrawing abstracts is 26 APRIL 2024. The Congress will not make any exceptions to this rule.
Important Abstract Dates
| Abstract Submission Deadline | 11 APRIL 2024 at 17:00 CET |
| Disclosure Submission Deadline | 11 APRIL 2024 at 17:00 CET |
| Abstract Notifications Mailed | 23 APRIL 2024 |
| Abstract Withdrawal Deadline | 26 APRIL 2024 |
| Abstract Presenter Early Registration Deadline | 10 MAY 2024 |
| Late-Breaking Abstract Deadline | 13 JUNE 2024 |
Support Desk/Questions?
Please click here to view our abstract submission FAQs. You may also submit a support form if your question is not included in our articles. The support form is available on each page of the submission site and questions are answered within a 24-hr period.
LOADING
